Eric Schwartz

Eric Schwartz is a declared insider at 2 companies (board member); the most frequent names are Integra Lifesciences Holdings Corp and Globus Medical Inc. Over a trading history stretching from 28 March 2018 to 11 March 2025, the count stands at 59 filings.

On the open market, the record shows 1 purchase worth €93k and 7 sales worth €2.1M. Sales outweigh purchases by €2.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 49 share grants and 2 option exercises.

The record was last updated on 13 March 2025 with a share grant (€26k) in Integra Lifesciences Holdings Corp. The most recent open-market purchase was published on 5 June 2023, 1,253 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.